1.
Braz. j. infect. dis
; Braz. j. infect. dis;10(6): 406-407, Dec. 2006.
Artículo
en Inglés
| LILACS
| ID: lil-446743
RESUMEN
Pegylated Interferon-alpha, combined with ribavirin, gives high sustained virological response in patients with hepatitis C virus, an important public health problem and one of the most frequent chronic infectious diseases worldwide. Though it has therapeutic benefits, treatment with IFN-alpha may be complicated by various side effects, especially symptoms of major depression and acute mania. Psychosis is a rare side effect, and its management usually includes discontinuation of IFN-alpha. We report a case of psychotic disorder that occurred during therapy with pegylated Interferon-alpha given associated with ribavirin. After good response to psychiatric treatment, it became possible to finish the anti-viral therapy.
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Antivirales/efectos adversos , Interferón-alfa , Polietilenglicoles/efectos adversos , Psicosis Inducidas por Sustancias/diagnóstico , Ribavirina/efectos adversos , Antipsicóticos/uso terapéutico , Quimioterapia Combinada , Hepatitis C Crónica , Psicosis Inducidas por Sustancias/tratamiento farmacológico , Risperidona/uso terapéutico
2.
Braz. J. Psychiatry (São Paulo, 1999, Impr.)
; Braz. J. Psychiatry (São Paulo, 1999, Impr.);26(2): 138-138, jun. 2004.
Artículo
en Portugués
| LILACS
| ID: lil-385242